Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

2,357 recalls · Class II, newest first

Class II · Moderate risk

Audiologist's Choice

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 59256-001-02 D-0682-2026
Class II · Moderate risk

TopCare Health

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 36800-835-33 D-0681-2026
Class II · Moderate risk

QC Quality Choice

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 63868-026-15 D-0680-2026
Class II · Moderate risk

Clinere

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 68229-102-01 D-0679-2026
Class II · Moderate risk

CVS Health

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 51316-822-00 D-0678-2026
Class II · Moderate risk

Nystatin Cream USP

Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

Ongoing Wrong potency / content Padagis US LLC NDC 45802-059-35 D-0677-2026
Class II · Moderate risk

Duloxetine D/R

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Ongoing Nitrosamine impurity Direct Rx NDC 61919-482-30 D-0617-2026
Class II · Moderate risk

Perampanel CIII Tablets

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Ongoing Labeling / mix-up Sun Pharmaceutical Industries INC NDC 51672-4206-6 D-0628-2026
Class II · Moderate risk

Synjardy XR Tablets

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Ongoing cGMP deviation Boehringer Ingelheim Pharmaceuticals, Inc. D-0657-2026
Class II · Moderate risk

Buprenorphine HCl

Crystallization; identified as Buprenorphine free base

Ongoing Failed specification Par Health USA, LLC NDC 42023-179-05 D-0596-2026
Class II · Moderate risk

BD ChloraPrep CLear

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-34 D-0652-2026
Class II · Moderate risk

BD ChloraPrep CLear

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0651-2026
Class II · Moderate risk

BD ChloraPrep Scrub Teal

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-39 D-0650-2026
Class II · Moderate risk

BD ChloraPrep Scrub Teal

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-36 D-0649-2026
Class II · Moderate risk

BD ChloraPrep Hi-Lite Orange

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-38 D-0648-2026
Class II · Moderate risk

BD ChloraPrep Hi-Lite Orange

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-33 D-0647-2026
Class II · Moderate risk

ChloraPrep FREPP

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-30 D-0646-2026

Recalls by year